David T. Vereide, Ph.D. - Publications
Affiliations: | 2009 | University of Wisconsin, Madison, Madison, WI |
Area:
Oncology, Microbiology Biology, Molecular BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Vereide DT, Vickerman V, Swanson SA, Chu LF, McIntosh BE, Thomson JA. An expandable, inducible hemangioblast state regulated by fibroblast growth factor. Stem Cell Reports. 3: 1043-57. PMID 25458896 DOI: 10.1016/J.Stemcr.2014.10.003 | 0.309 | |||
2014 | Vereide DT, Seto E, Chiu YF, Hayes M, Tagawa T, Grundhoff A, Hammerschmidt W, Sugden B. Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene. 33: 1258-64. PMID 23503461 DOI: 10.1038/Onc.2013.71 | 0.591 | |||
2011 | Howden SE, Gore A, Li Z, Fung HL, Nisler BS, Nie J, Chen G, McIntosh BE, Gulbranson DR, Diol NR, Taapken SM, Vereide DT, Montgomery KD, Zhang K, Gamm DM, et al. Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proceedings of the National Academy of Sciences of the United States of America. 108: 6537-42. PMID 21464322 DOI: 10.1073/Pnas.1103388108 | 0.328 | |||
2011 | Vereide DT, Sugden B. Lymphomas differ in their dependence on Epstein-Barr virus. Blood. 117: 1977-85. PMID 21088132 DOI: 10.1182/Blood-2010-05-285791 | 0.642 | |||
2010 | Vereide D, Sugden B. Insights into the evolution of lymphomas induced by Epstein-Barr virus. Advances in Cancer Research. 108: 1-19. PMID 21034964 DOI: 10.1016/B978-0-12-380888-2.00001-7 | 0.619 | |||
2009 | Vereide D, Sugden B. Proof for EBV's sustaining role in Burkitt's lymphomas. Seminars in Cancer Biology. 19: 389-93. PMID 19628040 DOI: 10.1016/J.Semcancer.2009.07.006 | 0.639 | |||
2009 | Dresang LR, Vereide DT, Sugden B. Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (EBNA1) in the human genome: defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes. Journal of Virology. 83: 2930-40. PMID 19129441 DOI: 10.1128/Jvi.01974-08 | 0.345 | |||
Show low-probability matches. |